According to a market report by Lucintel, the future of the global biofilm treatment market looks promising with opportunities in the seaport and inland port markets. The global biofilm treatment market is expected to reach an estimated $2 billion by 2030 from $1 billion in 2024 at a CAGR of 7.2% from 2024 to 2030. The major drivers for this market are increasing incidence of chronic wounds, rising prevalence of healthcare-associated infections, and growing demand for minimally invasive therapies.
A more than 180-page
report to understand trends,
opportunity and forecast in global biofilm treatment market to 2030 by product
(debridement equipment, gauzes and dressings, gels, ointments, and sprays,
grafts and matrices, and wipes, pads, and lavage solutions), wound type
(traumatic and surgical wounds, diabetic foot ulcers, pressure ulcers, venous
leg ulcers, and others), application (hospitals, ASCs, and wound care centers,
home care settings, and others.), and region (North America, Europe, Asia
Pacific, and the Rest of the World).
Lucintel forecasts that gauzes and dressings is expected to remain the
largest product segment over the forecast period due to the development of
innovative gauzes and dressings with antimicrobial properties and enhanced
moisture-retention capabilities is driving growth in this segment.
Within this market, Hospitals, ASCs, & Wound Care Centers will remain
the largest application segment as the
market for hospitals ASCs, and wound care centers is driven by presence of
advanced facilities, availability of trained staffs, and improvement in
healthcare infrastructure in developing nations and emergence of specialized
hospitals.
Download sample by clicking on biofilm treatment
market.
North America will remain the largest segment over the forecast period
because of presence of prominent players, such as MiMedx, and Medline
Industries, in the North American market. These players drive innovation and
market growth through product development and strategic partnerships. The FDA
and other regulatory bodies have stringent guidelines for biofilm treatment
products, ensuring safety and efficacy. This has led to the development of
innovative and effective treatment solutions in the region.
Smith & Nephew, MiMedx, ConvaTec, Coloplast A/S, Molnlycke
Healthcare, Organogenesis, Integra LifeSciences, B. Braun Melsungen, PAUL
HARTMANN, Medline Industries are the major suppliers in the biofilm treatment
market.
This unique research
report will enable you to make confident business decisions in this globally
competitive marketplace. For a detailed table of contents, contact Lucintel at
+1-972-636-5056 or write us at helpdesk@lucintel.com.
About Lucintel
At Lucintel, we offer solutions for
you growth through game changer ideas and robust market &
unmet needs analysis. We are based in
Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20
years. We are quoted in several publications like the Wall Street Journal,
ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1 972.636.5056
Explore Our Latest Publications
Semiconductor Gap Fill Material Market in Canada
Smoke Ingredient Food Market in Canada
Specialty Fertilizer Market in Canada
No comments:
Post a Comment